Contrast-enhanced sonography for prostate cancer detection in patients with indeterminate clinical findings

American Journal of Roentgenology

Volumn 186, Issue 5, 2006, Pages 1431-1435

  Yi, Ahn ^a   Jeong, Kon Kim ^a   Seong, Ho Park ^a   Kyoung, Won Kim ^a   Ho, Sung Kim ^a   Jung, Hoon Kim ^b   Hyo, Won Eun ^c   Cho, Kyoung Sik ^a  

^a University of Ulsan   (South Korea)

^b Soonchunhyang University College of Medicine   (South Korea)

^c Seoul National University Hospital Healthcare System Gangnam Center   (South Korea)

Author keywords

Cancer; Prostate; Prostate specific antigen; Sonography

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; SHU 508; CONTRAST MEDIUM;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CLINICAL ARTICLE; COLOR ULTRASOUND FLOWMETRY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIGITAL RECTAL EXAMINATION; ECHOGRAPHY; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; SENSITIVITY AND SPECIFICITY; BLOOD; MIDDLE AGED; PROSPECTIVE STUDY; PROSTATE TUMOR;

AGED; CONTRAST MEDIA; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; SENSITIVITY AND SPECIFICITY;

EID: 33745550834     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/AJR.04.1959     Document Type: Article

References (23)

1. Halpern EJ, Rosenberg M, Gomella LG. Prostate cancer: contrast-enhanced US for detection. Radiology 2001; 219:219-225
2. Unal D, Sedelaar JP, Aarnink RG, et al. Three-dimensional contrast-enhanced power Doppler ultrasonography and conventional examination methods: the value of diagnostic predictors of prostate cancer. BJU Int 2000; 86:58-64
3. Clements R. Ultrasound of prostate cancer. Eur Radiol 2001; 11:2119-2125
4. Lee F, Torp-Pedersen S, Littrup PJ, et al. Hypoechoic lesions of the prostate: clinical relevance of tumor size, digital rectal examination, and prostate-specific antigen. Radiology 1989; 170:29-32
5. Kuligowska E, Barish MA, Fenlon HM, Blake M. Predictors of prostate carcinoma: accuracy of grayscale and color Doppler US and serum markers. Radiology 2001; 220:757-764
6. Halpern EJ, Strup SE. Using gray-scale and color and power Doppler sonography to detect prostatic cancer. AJR 2000; 174:623-627
7. Kelly IMG, Lees WR, Rickards D. Prostate cancer and the role of color Doppler US. Radiology 1993; 189:153-156
8. Lavoipierre AM, Snow RM, Frydenberg M, et al. Prostatic cancer: the role of color Doppler imaging in transrectal sonography. AJR 1998; 171:205-210
9. Halpern EJ, Verkh L, Forsberg F, Gomella LG, Mattrey RF, Goldberg BB. Initial experience with contrast-enhanced sonography of the prostate. AJR 2000; 174:1575-1580
10. Roy C, Buy X, Lang H, Saussine C, Jacqmin D. Contrast enhanced color Doppler endorectal sonography of prostate: efficiency for detecting peripheral zone tumors and role for biopsy procedure. J Urol 2003; 170:69-72
11. Goossen TE, de la Rosette JJ, Hulsbergen-van de Kaa CA, van Leenders GJ, Wijkstra H. The value of dynamic contrast enhanced power Doppler ultrasound imaging in the localization of prostate cancer. Eur Urol 2003; 43:124-131
12. Frauscher F, Klauser A, Volgger H, et al. Comparison of contrast enhanced color Doppler targeted biopsy with conventional systematic biopsy: impact on prostate cancer detection. J Urol 2002; 167:1648-1652
13. Halpern EJ, Frauscher F, Rosenberg M, Gomella LG. Directed biopsy during contrast-enhanced sonography of the prostate. AJR 2002; 178:915-919
14. Karaman CZ, Unsal A, Akdili A, Taskin R, Erol H. The value of contrast enhanced power Doppler ultrasonography in differentiating hypoechoic lesions in the peripheral zone of prostate. Eur J Radiol 2005; 54:148-155
15. Gettman MT, Pacelli A, Slezak J, et al. Role of microvessels density in predicting recurrence in pathologic stage T3 prostatic adenocarcinoma. Urology 1999; 54:479-485
16. Cornud F, Belin X, Piron D, et al. Color Doppler-guided prostate biopsies in 591 patients with an elevated serum PSA level: impact on Gleason score for nonpalpable lesions. Urology 1997; 49:709-715
17. Bigler SA, Deering RE, Brawer MK. Comparison of microscopic vascularity in benign and malignant prostate tissue. Hum Pathol 1993; 24:220-226
18. Silberman MA, Partin AW, Veltri RW, Epstein JI. Tumor angiogenesis correlates with progression after radical prostatectomy but not with pathologic stage in Gleason sum 5 to 7 adenocarcinoma of the prostate. Cancer 1997; 79:772-779
19. Aarnink RG, Beerlage HP, De La Rosette JJ, Debruyne FM, Wijkstra H. Endorectal ultrasound of the prostate: innovations and future applications. J Urol 1998; 159:1568-1579
20. Correas JM, Bridal L, Lesavre A, et al. Ultrasound contrast agents: properties, principles of action, tolerance, and artifacts. Eur Radiol 2001; 11:1316-1328
21. Harvey CJ, Blomley MJ, Eckersley RJ, Cosgrove DO. Developments in ultrasound contrast media. Eur Radiol 2001; 11:675-689
22. Norberg M, Egevad L, Holmberg L, Sparen P, Norlen BJ, Busch C. The sextant protocol for ultrasound-guided biopsies of the prostate underestimates the presence of cancer. Urology 1997; 50:562-566
23. Eskew LA, Bare RL, McCullough DL. Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate. J Urol 1997; 157:199-203